AI Summary
This article focuses on the development and evaluation of a radiolabeled riboflavin derivative for PET imaging of melanoma in mice. The study aims to target RFVT3, a potential biomarker for melanoma, using Gallium-68. The findings could contribute to improving early detection and monitoring of melanoma, potentially leading to better treatment outcomes.
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.4c00209